{
    "abstractText": "Introduction: IgG4 related disease (IgG4-RTD) is an infrequent disease with possible multiple organ involvement. It is characteristic to find inflammatory nodules with IgG4 positive plasma cell infiltration, storiform fibrosis and obliterative phlebitis. We present a patient with an inflammatory pseudotumor in the right upper lobe, mimicking a primary lung tumor. Case report: Our patient, a 48-year old heavy smoker (25 pack/year) with no relevant medical background, referred chest pain, non-productive cough and sporadic nightly fever. Image findings revealed a mass in the right upper lobe, with increased SUV in PET-scan, and mediastinal lymphadenopathies. Primary lung tumor was suspected and right upper lobectomy was performed. Due to absence of cellular atypia and the intense plasmacytic activity in the lesion, immunohistochemical analysis was performed: abundant IgG4 plasma cells were identified, with a IgG4/IgG relation of 74%. Diagnosis of IgG4inflammatory pseudotumor was made. Discussion: After an extensive bibliographic review, we found just one similar case reported with an IgG4-lung pseudotumor without systemic disease. Due to the broad spectrum of clinical features of IgG4-RTD, and the potential multiple organ involvement, it is hard to find a classification and diagnostic criteria with high sensitivity and specificity, nevertheless they can be useful in clinical practice. Conclusion: There are several benign inflammatory diseases which can mimic a primary lung tumor. Although incidence is low, IgG4 pseudotumor should be considered as a differential diagnosis in the absence of malignancy.",
    "authors": [
        {
            "affiliations": [],
            "name": "Tom\u00e1s Seip"
        },
        {
            "affiliations": [],
            "name": "Francisco Calder\u00f3n Novoa"
        },
        {
            "affiliations": [],
            "name": "Melina Paula Valeo Chulvi"
        },
        {
            "affiliations": [],
            "name": "David Smith"
        },
        {
            "affiliations": [],
            "name": "Agust\u00edn Dietrich"
        }
    ],
    "id": "SP:d304c7bfe4625124c1978cd5c3a4d18a16ad712e",
    "references": [
        {
            "authors": [
                "AT Morales",
                "AG Cignarella",
                "IS Jabeen",
                "JS Barkin",
                "M. Mirsaeidi"
            ],
            "title": "An update on IgG4-related lung disease",
            "venue": "Eur J Intern Med",
            "year": 2019
        },
        {
            "authors": [
                "ZS Wallace",
                "RP Naden",
                "S Chari",
                "HK Choi",
                "E Della-Torre",
                "JF Dicaire",
                "PA Hart",
                "D Inoue",
                "M Kawano",
                "A Khosroshahi",
                "M Lanzillotta",
                "K Okazaki",
                "CA Perugino",
                "A Sharma",
                "T Saeki",
                "N Schleinitz",
                "N Takahashi",
                "H Umehara",
                "Y Zen",
                "JH Stone"
            ],
            "title": "Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease",
            "venue": "Ann Rheum Dis",
            "year": 2020
        },
        {
            "authors": [
                "SN Campbell",
                "E Rubio",
                "AL. Loschner"
            ],
            "title": "Clinical review of pulmonary manifestations of IgG4-related disease",
            "venue": "Ann Am Thorac Soc. 2014 Nov;11(9):1466-75. doi: 10.1513/AnnalsATS.201403-128FR",
            "year": 2014
        },
        {
            "authors": [
                "M Kitada",
                "Y Matuda",
                "S Hayashi",
                "K Ishibashi",
                "K Oikawa",
                "N Miyokawa",
                "Y. Ohsaki"
            ],
            "title": "IgG4-related lung disease showing high standardized uptake values on FDG-PET: report of two cases",
            "venue": "J Cardiothorac Surg. 2013 Jun 25;8:160",
            "year": 2013
        },
        {
            "authors": [
                "H Umehara",
                "K Okazaki",
                "T Nakamura",
                "T Satoh-Nakamura",
                "A Nakajima",
                "M Kawano",
                "T Mimori",
                "T. Chiba"
            ],
            "title": "Current approach to the diagnosis of IgG4-related disease Combination of comprehensive diagnostic and organspecific criteria",
            "venue": "Mod Rheumatol",
            "year": 2017
        }
    ],
    "sections": [
        {
            "text": "plasm\u00e1ticas IgG4 positivas. Por esto consideramos que, en los casos de masa pulmonar sin evidencia de atipias celulares la enfermedad por IgG4 es un diagn\u00f3stico diferencial a tener en cuenta."
        },
        {
            "heading": "CONCEPTOS CLAVES:",
            "text": ""
        },
        {
            "heading": "Qu\u00e9 se sabe sobre el tema",
            "text": "La enfermedad relacionada con IgG4 fue descrita en\nlos a\u00f1os \u201890 y se caracteriza por su compromiso\nmultiorg\u00e1nico y presentaci\u00f3n cl\u00ednica variable, por lo\ncual se establecieron m\u00faltiples criterios diagn\u00f3sticos\ny clasificaciones. A nivel pulmonar se puede\npresentar como neumon\u00eda intersticial, adenopat\u00edas\nmediastinales y pulmonares o pseudotumor\ninflamatorio. El diagn\u00f3stico se confirma con el\nestudio histopatol\u00f3gico por la presencia de\ninfiltrados de c\u00e9lulas plasm\u00e1ticas y tiene buena\nrespuesta al tratamiento con corticoides."
        },
        {
            "heading": "Qu\u00e9 aporta este trabajo",
            "text": "El caso presentado a continuaci\u00f3n es de un paciente\ncon un pseudotumor inflamatorio en el v\u00e9rtice\npulmonar derecho sin compromiso sist\u00e9mico que\nsimula un tumor primario de pulm\u00f3n. Si bien\nconstituye una presentaci\u00f3n cl\u00ednica at\u00edpica,\nconsideramos que se debe tener en cuenta al\npseudotumor por IgG4 como diagn\u00f3stico diferencial\nde masa pulmonar, una vez descartada la causa\nneopl\u00e1sica.\nRecibido: 2021-09-06 Aceptado: 2022-09-08 DOI: http://dx.doi.org/10.31053/1853.0605.v80.n1.34753\nhttps://creativecommons.org/licenses/by-nc/4.0/ \u00a9Universidad Nacional de C\u00f3rdoba\nIntroduction: IgG4 related disease (IgG4-RTD) is an infrequent disease with possible multiple organ involvement. It is characteristic to find inflammatory nodules with IgG4 positive plasma cell infiltration, storiform fibrosis and obliterative phlebitis. We present a patient with an inflammatory pseudotumor in the right upper lobe, mimicking a primary lung tumor. Case report: Our patient, a 48-year old heavy smoker (25 pack/year) with no relevant medical background, referred chest pain, non-productive cough and sporadic nightly fever. Image findings revealed a mass in the right upper lobe, with increased SUV in PET-scan, and mediastinal lymphadenopathies. Primary lung tumor was suspected and right upper lobectomy was performed. Due to absence of cellular atypia and the intense plasmacytic activity in the lesion, immunohistochemical analysis was performed: abundant IgG4 plasma cells were identified, with a IgG4/IgG relation of 74%. Diagnosis of IgG4- inflammatory pseudotumor was made. Discussion: After an extensive bibliographic review, we found just one similar case reported with an IgG4-lung pseudotumor without systemic disease. Due to the broad spectrum of clinical features of IgG4-RTD, and the potential multiple organ involvement, it is hard to find a classification and diagnostic criteria with high sensitivity and specificity, nevertheless they can be useful in clinical practice. Conclusion: There are several benign inflammatory diseases which can mimic a primary lung tumor. Although incidence is low, IgG4 pseudotumor should be considered as a differential diagnosis in the absence of malignancy.\nKeywords: immunoglobulin g4-related disease; plasma cell granuloma; lung neoplasms.\nReporte de caso: pseudotumor inflamatorio por IgG4 simulando c\u00e1ncer de pulm\u00f3n\nRESUMEN\nIntroducci\u00f3n: La enfermedad relacionada con IgG4 (IgG4-RTD) es una enfermedad poco frecuente con posible afectaci\u00f3n multiorg\u00e1nica. La presencia de infiltrados linfoplasmocitarios con c\u00e9lulas plasm\u00e1ticas positivas para IgG4, fibrosis y flebitis obliterante. Presentamos el caso de un paciente con un pseudotumor inflamatorio en el l\u00f3bulo superior derecho, con presentaci\u00f3n cl\u00ednica compatible con tumor primario de pulm\u00f3n. Caso cl\u00ednico: Nuestro paciente de 48 a\u00f1os de edad, tabaquista severo (25 paquetes / a\u00f1o) sin antecedentes m\u00e9dicos relevantes, consulta por dolor tor\u00e1cico, tos no productiva y registros subfebriles aislados. Presenta una masa en el l\u00f3bulo superior derecho en estudio por imagen, con aumento de la captaci\u00f3n en el PET, asociado a adenopat\u00edas mediast\u00ednicas. Con diagn\u00f3stico inicial de c\u00e1ncer de pulm\u00f3n, se realiz\u00f3 lobectom\u00eda superior derecha. Debido a la ausencia de atipia celular y la presencia de infiltrados linfoplasmocitarios en la lesi\u00f3n, se realiz\u00f3 an\u00e1lisis inmunohistoqu\u00edmico: se identificaron abundantes c\u00e9lulas plasm\u00e1ticas positivas para IgG4, con una relaci\u00f3n IgG4 / IgG del 74%. Se realiz\u00f3 el diagn\u00f3stico de pseudotumor inflamatorio por IgG4. Discusi\u00f3n: Tras una extensa revisi\u00f3n bibliogr\u00e1fica, s\u00f3lo encontramos un caso similar, de una paciente con un pseudotumor pulmonar IgG4 sin enfermedad sist\u00e9mica. Debido a la variabilidad de la presentaci\u00f3n cl\u00ednica de la enfermedad relacionada a IgG4, y su potencial afectaci\u00f3n multiorg\u00e1nica, es dif\u00edcil encontrar una clasificaci\u00f3n y criterios diagn\u00f3sticos con alta sensibilidad y especificidad, sin embargo estos suelen ser \u00fatiles en la pr\u00e1ctica cl\u00ednica. Conclusi\u00f3n: M\u00faltiples enfermedades inflamatorias son diagn\u00f3stico diferencial de tumor primario de pulm\u00f3n. Si bien la incidencia es baja, el pseudotumor IgG4 debe considerarse como un diagn\u00f3stico diferencial cuando no hay evidencia de enfermedad neopl\u00e1sica.\nPalabras claves: granuloma de c\u00e9lulas plasm\u00e1ticas; enfermedad relacionada con inmunoglobulina g4; neoplasias pulmonares."
        },
        {
            "heading": "Pseudotumor inflamat\u00f3rio IgG4 simulando",
            "text": "c\u00e2ncer de pulm\u00e3o: relato de caso\nRESUMO\nIntrodu\u00e7\u00e3o: A doen\u00e7a relacionada com IgG4 (IgG4-RTD) \u00e9 uma doen\u00e7a infrequente com poss\u00edvel envolvimento de m\u00faltiplos \u00f3rg\u00e3os. \u00c9 caracter\u00edstico encontrar n\u00f3dulos inflamat\u00f3rios com infiltra\u00e7\u00e3o de c\u00e9lulas plasm\u00e1ticas positivas para IgG4, fibrose estoriforme e flebite obliterativa. Apresentamos um paciente com pseudotumor inflamat\u00f3rio no lobo superior direito, simulando ser um tumor prim\u00e1rio de pulm\u00e3o. Relato de caso: Nosso paciente, fumador, faz mais de 48 anos (25 ma\u00e7os / ano) sem hist\u00f3ria m\u00e9dica relevante, referia dor no peito, tosse n\u00e3o produtiva e febre noturna espor\u00e1dica. As imagens revelaram uma massa no lobo superior direito, com SUV aumentado no PET-scan e linfadenopatias mediastinais. Suspeitou-se de um tumor prim\u00e1rio de pulm\u00e3o e realizou-se lobectomia superior direita. Devido \u00e0 aus\u00eancia de atipia celular e \u00e0 intensa atividade plasmoc\u00edtica na les\u00e3o a pe\u00e7a foi estudada com an\u00e1lise imunoistoqu\u00edmica: foram identificados plasm\u00f3citos IgG4 + abundantes, com rela\u00e7\u00e3o IgG4 / IgG de 74%. Chegou-se ao diagn\u00f3stico de pseudotumor inflamat\u00f3rio por IgG4. Discuss\u00e3o: Ap\u00f3s uma extensa revis\u00e3o bibliogr\u00e1fica, encontramos apenas um registro semelhante relatado com um pseudotumor de pulm\u00e3o IgG4 sem doen\u00e7a sist\u00eamica. Devido ao amplo espectro de caracter\u00edsticas cl\u00ednicas do IgG4-RTD e ao potencial envolvimento de m\u00faltiplos \u00f3rg\u00e3os, \u00e9 dif\u00edcil encontrar uma classifica\u00e7\u00e3o e crit\u00e9rios diagn\u00f3sticos com alta sensibilidade e especificidade; no entanto, eles podem ser \u00fateis na pr\u00e1tica cl\u00ednica. Conclus\u00e3o: Existem v\u00e1rias doen\u00e7as inflamat\u00f3rias benignas que podem mimetizar um tumor pulmonar prim\u00e1rio. Embora a incid\u00eancia seja baixa, o pseudotumor de IgG4 deve ser considerado como diagn\u00f3stico diferencial na aus\u00eancia de malignidade.\nPalavras-chave: doen\u00e7a relacionada a imunoglobulina g4; granuloma de c\u00e9lulas plasm\u00e1ticas; neoplasias pulmonares."
        },
        {
            "heading": "INTRODUCTION",
            "text": "IgG4 related disease (IgG4-RTD) is an infrequent disease which most commonly affects elderly male patients, originally described in the 1990s. Several reports show evidence of multiple organ involvement, such as salivary glands, orbital structures, pancreas and kidneys, among others. It is characteristic to find inflammatory nodules with IgG4 positive plasma cell infiltration, storiform fibrosis and obliterative phlebitis(1). In the year 2019 a new classification was proposed by the American College of Rheumatology and the European League Against Rheumatism(2). Pulmonary IgG4 related disease has a wide spectrum, and may present itself as nonspecific interstitial pneumonia, inflammatory pseudotumor\nor lymphadenopathies(1). We present a patient with an inflammatory pseudotumor in the right upper lobe, with no evidence of extrapulmonary involvement, clinically indistinguishable from a primary lung tumor."
        },
        {
            "heading": "CASE REPORT",
            "text": "We present a 48-year old heavy smoker (25 pack/year) with no relevant medical background. His chief complaint was a low intensity, constant chest pain, with non-productive cough and sporadic nightly fever. Chest x-ray revealed a radiopaque mass in the right upper lobe without pleural effusion, pneumotorax or lung consolidation (figure 1). SARS-Cov2 infection was ruled out by polymerase-chain-\nreaction. CT-scan showed an irregular mass with spiculated edges of 47 x 50.5 mm and pleural retraction, along with pathological mediastinal lymph nodes (over 10 mm) (figure 2). Tumor staging studies were performed: PET-scan showed increased uptake of the lung mass (SUV 10) and mediastinal and hilar lymph nodes with a slightly increased uptake (2.8 and 3.9 SUV respectively) (figure 3). There was no evidence of disseminated disease in the PET-Scan or brain-MRI. Given the patient's history and imagenological findings, locally advanced primary lung tumor was suspected. Esophageal ultrasound (EUS) was performed, with no evidence of esophageal infiltration.\nFigure N\u00b01. Initial chest x-ray. X-ray showing an area of increased density in the upper right lobe, near the vertex, with no evidence of associated pleural\neffusion or pneumothorax.\nFigure N\u00b02. Preoperative non-enhanced computed tomography showing mass of 47 x 50.5 mm in axial (C, D) and coronal (A, B) planes, which is in\nintimate contact with the esophagus.\nFigure N\u00b03. Pet-scan showing increased SUV in already known mass in right upper lung vertex (SUV 10) (A, C) and mediastinal and right hilar subcentimeter\nlymph nodes (SUV 2.8 and 3.9) (B). No other organs with pathological findings were evidenced by this method.\nPrior to oncological resection, lymph node biopsy of groups 2R, 4R, 4L and 7 (which had high uptake on PEt-scan) was performed by videomediastinoscopy. Pathology results were positive for antracosis, with no signs of cellular atypia. The case was discussed in a multidisciplinary committee and surgical resection was decided. Video assisted thoracoscopic right upper lobectomy with lymphadenectomy was performed. The patient had no immediate complications, and spent 72 hours in the intensive care unit for routine monitoring. The patient was discharged on day six. 15 days later, postoperative control showed no late complications. Histopathologic study revealed an inflammatory process with necrotic areas and lymphoplasmacytic infiltration. The entire lung mass was thoroughly analyzed in his whole extension (4,5 x 3,2 cm) and no cellular atypia were found. Anthracosis and reactive changes were found at the lymph nodes. Due to the absence of atypical cells and the intense plasmacytic activity in the lesion, immunohistochemical analysis was performed: 294\nIgG positive plasma cells per high-power-field (HPF) and 219 IgG4 plasma cells per high-power-field were identified, with a IgG4/IgG relation of 74%.\nFigure 4. With these findings, diagnosis of IgG4inflammatory pseudotumor was made. Serum IgG4 levels were measured, with a total of 244 mg/dL, superior to reference range.\nFigure N\u00b04. Tissue samples of the lung mass. A: dense lymphoplasmacytic infiltration with eosinophils (Hematoxylin and eosin staining, original magnification\nx400). B: IgG positive plasma cells evidenced with immunostaining in a high power field (immunohistochemistry, original magnificaction x400). C: IgG4\npositive plasma cells evidenced in a high power field (immunohistochemistry, original magnification x400).\nD ISCUSSION\nIgG4 related disease with lung involvement is uncommon and is usually seen in cases of multiorganic affection(3). After an extensive bibliographic review, we found but one similar case reported, of a japanese woman with an IgG4-lung pseudotumor without systemic disease(4). In the year 2011 the comprehensive Criteria for IgG4 related disease were proposed(5). These include: a) swelling or masses in single o multiple\norgans, b) elevated levels of serum IgG4 (>135mg/dL), c) lymphocytic and plasmacytic infiltration and fibrosis in histopathologic analysis or presence of IgG4 plasma cells. When criteria A. and C. are met, the diagnosis of IgG4 related disease is probable. If the IgG4 serum levels are elevated, the diagnosis is definite. Our patient fulfilled all of the criteria: a lung mass with marked lymphoplasmacytic infiltration and fibrosis, associated with high IgG/IgG4 proportion (74%) and IgG4-serum levels of 244 mg/dL. The American College of Rheumatology and the European League Against Rheumatism developed a new classification for IgG4-RTD in the year 2019. These criteria were proposed by a multispecialty group of 86 physicians based on a cohort of 1879 patients and the existing literature. Our patient patient would not be classified as having IgG4-RTD following this classification because of meeting some of the exclusion criteria (fever and radiological findings suspicious of malignancy) and not presenting the inclusion criteria of lung\ninvolvement (e.g. peribronchovascular or septal\nthickening evidenced in cross-sectional image study or paravertebral band-like soft tissue). However the diagnosis was confirmed by histopathological and immunohistochemical analysis. Due to the broad spectrum of clinical features of IgG4-RTD, and the potential multiple organ involvement, it is hard to find a classification and diagnostic criteria with high sensitivity and specificity. Even though the classifications published in the literature can be useful in clinical practice, one must take into account that some cases do not necessarily fulfill the criteria to be considered as IgG4-RTD, like our patient. There are several benign inflammatory diseases (e.g. sarcoidosis, Castlemann disease) which can mimic a primary lung tumor. Although incidence is low, IgG4-RTD presenting as a lung pseudotumor without other organ involvement is a differential diagnosis to be considered in the case no malignancy is found. When IgG4-RTD is diagnosed, corticosteroids are the first line treatment, showing improvement of radiological findings and symptoms."
        },
        {
            "heading": "CONCLUSION",
            "text": "IgG4 related disease is an infrequent and variable disease which can mimic a primary lung tumor. Even though incidence is low it is a differential diagnosis to be considered, once malignancy is ruled out. Several classifications and diagnostic criteria published in the last years are useful to identify this disease. However, not all of them suited our patient and IgG4-RTD was confirmed upon/with pathological findings."
        },
        {
            "heading": "CONFLICT OF INTEREST STATEMENT",
            "text": "El estudio se llev\u00f3 a cabo en total acuerdo con la normativa nacional e internacional vigente: Declaraci\u00f3n de Helsinki de la Asociaci\u00f3n M\u00e9dica Mundial y las Normas de Buenas Pr\u00e1cticas Cl\u00ednicas"
        },
        {
            "heading": "ICH E6.",
            "text": "La participaci\u00f3n en el estudio fue en todos los casos voluntaria y certificada por el proceso de consentimiento informado. Se respet\u00f3 en todo momento el derecho a la no participaci\u00f3n en el estudio sin que esto implique en ning\u00fan caso alg\u00fan tipo de discriminaci\u00f3n, trato diferencial o maltrato. En todo momento se observ\u00f3 la protecci\u00f3n de la identidad y los datos del paciente acorde a la normativa legal vigente ley nacional de protecci\u00f3n de datos personales 25.326 (Habeas Data), en concordancia con la normativa internacional sobre registro de enfermedades y protecci\u00f3n de datos personales y privados, de acuerdo con 18th World Medical Assembly de Helsinki (1964) cuando aplique. La confidencialidad de los datos estuvo garantizada ya que los datos identificatorios de los pacientes fueron separados de los datos cl\u00ednicos obtenidos en el estudio, utilizando n\u00famero de ID y no el nombre de los pacientes en lo que respecta al armado de planillas y bases de datos. Las t\u00e9cnicas utilizadas fueron no invasivas, se efectu\u00f3 en la pr\u00e1ctica cotidiana y no conllev\u00f3 riesgos para el\npaciente, por lo que no se requiri\u00f3 la contrataci\u00f3n de un seguro."
        }
    ],
    "title": "IgG4 inflammatory pseudotumor mimicking primary lung cancer: a case report",
    "year": 2023
}